TPST Return on Tangible Equity | Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc. (TPST) Return on Tangible Equity

2026-06-30: Return Tang Equity 3713.03%.
2026-03-31: Return Tang Equity -5243.07%.
2025-12-31: Return Tang Equity -393.85%.
2025-09-30: Return Tang Equity -568.14%.

Complete source-backed return tang equity history.

Available history: 2012-06-30 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	3713.03%
2026-03-31	-5243.07%
2025-12-31	-393.85%
2025-09-30	-568.14%
2025-06-30	-440.55%
2025-03-31	-402.40%
2024-12-31	-218.78%
2024-09-30	-310.01%
2024-06-30	-187.43%
2024-03-31	-144.24%
2023-12-31	-110.17%
2023-09-30	2613.95%
2023-06-30	-663.75%
2023-03-31	-317.87%
2022-12-31	-197.17%
2022-09-30	-128.43%
2022-06-30	-96.04%
2022-03-31	-107.09%
2021-12-31	-78.36%
2021-09-30	57.06%
2021-06-30	-46.07%
2021-03-31	27.50%
2020-12-31	39.22%
2020-09-30	54.69%
2020-06-30	70.00%
2020-03-31	84.82%
2019-12-31	88.49%
2019-09-30	-98.48%
2019-06-30	-72.35%
2019-03-31	-54.13%
2018-12-31	-38.33%
2018-09-30	-130.87%
2018-06-30	-120.70%
2018-03-31	-128.97%
2017-12-31	64.72%
2017-09-30	-90.04%
2017-06-30	-92.45%
2017-03-31	-79.60%
2016-12-31	-76.01%
2016-09-30	-61.76%
2016-06-30	-53.80%
2016-03-31	-71.45%
2015-12-31	-57.72%
2015-09-30	-50.15%
2015-06-30	-42.44%
2015-03-31	-34.84%
2014-12-31	-89.51%
2014-09-30	-60.66%
2014-06-30	-45.23%
2014-03-31	-36.69%
2013-12-31	-69.65%
2013-09-30	-45.38%
2013-06-30	-33.93%
2013-03-31	-26.58%
2012-12-31	-43.98%
2012-09-30	-29.33%
2012-06-30	92.10%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-393.85%
2024-12-31	-218.78%
2023-12-31	-110.17%
2022-12-31	-197.17%
2021-12-31	-78.36%
2020-12-31	27.92%
2019-12-31	88.49%
2018-12-31	-38.33%
2017-12-31	64.71%
2016-12-31	-76.01%
2015-12-31	-57.72%
2014-12-31	-89.51%
2013-12-31	-69.65%
2012-12-31	-43.98%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Aspire Biopharma Holdings, Inc. (ASBP)	United States	$0.012B	-0.60
AEON Biopharma, Inc. (AEON)	United States	$0.013B	-0.36
BIOVIE INC. (BIVI)	United States	$0.012B
MUSTANG BIO, INC. (MBIO)	United States	$0.013B
Vistagen Therapeutics, Inc. (VTGN)	United States	$0.013B	-0.14
ADIAL PHARMACEUTICALS, INC. (ADIL)	United States	$0.012B
Phio Pharmaceuticals Corp. (PHIO)	United States	$0.012B	-0.92
Scienture Holdings, Inc. (SCNX)	United States	$0.012B	-0.38
LISATA THERAPEUTICS, INC. (LSTA)	United States	$0.014B	-2.13
KIORA PHARMACEUTICALS INC (KPRX)	United States	$0.012B